Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 1770-1777

  Martin, Christopher ^a,b   Connelly, Alexandra ^a   Keku, Temitope O ^a,b   Mountcastle, Sally B ^a   Galanko, Joseph ^b   Woosley, John T ^b   Schliebe, Barbara ^b   Lund, P Kay ^c   Sandler, Robert S ^a,b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLEVE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADENOMATOUS POLYP; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; COLON ADENOMA; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECTUM ADENOMA;

EID: 0036893756     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37053     Document Type: Article

References (30)

1. Hamilton SR. Origin of colorectal cancers in hyperplastic polyps and serrated adenomas: Another truism bites the dust. J Natl Cancer Inst 2001;93:1282-1283.
2. Moss SF, Liu TC, Petrotos A, Hsu TM, Gold LI, Holt PR. Inward growth of colonic adenomatous polyps. Gastroenterology 1996;111:1425-1432.
3. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:6843-6868.
4. Whittemore AS. Colorectal cancer incidence among Chinese in North America and the People's Republic of China: Variation with sex, age, and anatomical site. Int J Epidemiol 1989;18:563-568.
5. Thomas DB, Karagas MR. Cancer in first and second generation Americans. Cancer Res 1987;47:5771-5776.
6. Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980;64:1323-1327.
7. Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993;14:1493-1497.
8. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-4404.
9. Sandier RS, Galanko JC, Murray SC, Helm JF, Woosley JT. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology 1998;114:441-447.
10. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
11. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-1952.
12. Wong BC, Zhu GH, Lam SK. Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 1999;53:315-318.
13. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995;96:491-503.
14. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995;55:3110-3116.
15. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995;109:994-998.
16. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-469.
17. Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 2000;60:3823-3831.
18. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-1816.
19. Ahnen DJ, Byers T. Proliferation happens. JAMA 1998;280:1095-1096.
20. Sandler RS, Baron JA, Tosteson TD, Mandel JS, Haile RW. Rectal mucosal proliferation and risk of colorectal adenomas: Results from a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2000;9:653-656.
21. Keku TO, Galanko JA, Murray SC, Woosley JT, Sandler RS. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 1998;7:993-999.
22. Wong WM, Mandir N, Goodlad RA, Wong BC, Garcia SB, Lam SK, Wright NA. Histogenesis of human colorectal adenomas and hyperplastic polyps: The role of cell proliferation and crypt fission. Gut 2002;50:212-217.
23. Mills SJ, Mathers JC, Chapman PD, Burn J, Gunn A. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 2001;48:41-46.
24. Goodlad RA, Levi S, Lee CY, Mandir N, Hodgson H, Wright NA. Morphometry and cell proliferation in endoscopic biopsies: Evaluation of a technique. Gastroenterology 1991;101:1235-1241.
25. Sandler RS. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Important Adv Oncol 1996;123-137.
26. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993;122:518-523.
27. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-1177.
28. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Paranka NS, Baier M, Emerson S, Pamukcu R. Antiproliferative effect of nonsteroidal anti-inflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 1994;3:433-438.
29. Ahnen DJ. Colon cancer prevention by NSAIDs: What is the mechanism of action? Eur J Surg 1998;(Suppl)111-114.
30. Keller JJ, Johan G, Offerhaus A, Hylind LM, Giardiello FM. Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev 2002;670-671.